OBJECTIVE: To test the hypothesis that heart rate characteristics (HRC) monitoring improves neonatal outcomes. STUDY DESIGN: We conducted a two-group, parallel, individually randomized controlled clinical trial of 3003 very low birth weight infants in 9 neonatal intensive care units. In one group, HRC monitoring was displayed; in the other, it was masked. The primary outcome was number of days alive and ventilator-free in the 120 days after randomization. Secondary outcomes were mortality, number of ventilator days, neonatal intensive care unit stay, and antibiotic use. RESULTS: The mortality rate was reduced in infants whose HRC monitoring was displayed, from 10.2% to 8.1% (hazard ratio, 0.78; 95% CI, 0.61-0.99; P = .04; number needed to monitor = 48), and there was a trend toward increased days alive and ventilator-free (95.9 of 120 days compared with 93.6 in control subjects, P = .08). The mortality benefit was concentrated in infants with a birth weight <1000 g (hazard ratio, 0.74; 95% CI, 0.57-0.95; P = .02; number needed to monitor = 23). There were no significant differences in the other outcomes. CONCLUSION: HRC monitoring can reduce the mortality rate in very low birth weight infants.
RCT Entities:
OBJECTIVE: To test the hypothesis that heart rate characteristics (HRC) monitoring improves neonatal outcomes. STUDY DESIGN: We conducted a two-group, parallel, individually randomized controlled clinical trial of 3003 very low birth weight infants in 9 neonatal intensive care units. In one group, HRC monitoring was displayed; in the other, it was masked. The primary outcome was number of days alive and ventilator-free in the 120 days after randomization. Secondary outcomes were mortality, number of ventilator days, neonatal intensive care unit stay, and antibiotic use. RESULTS: The mortality rate was reduced in infants whose HRC monitoring was displayed, from 10.2% to 8.1% (hazard ratio, 0.78; 95% CI, 0.61-0.99; P = .04; number needed to monitor = 48), and there was a trend toward increased days alive and ventilator-free (95.9 of 120 days compared with 93.6 in control subjects, P = .08). The mortality benefit was concentrated in infants with a birth weight <1000 g (hazard ratio, 0.74; 95% CI, 0.57-0.95; P = .02; number needed to monitor = 23). There were no significant differences in the other outcomes. CONCLUSION: HRC monitoring can reduce the mortality rate in very low birth weight infants.
Authors: Margaret S Pepe; Ziding Feng; Ying Huang; Gary Longton; Ross Prentice; Ian M Thompson; Yingye Zheng Journal: Am J Epidemiol Date: 2007-11-02 Impact factor: 4.897
Authors: Karen D Fairchild; Varadamurthy Srinivasan; J Randall Moorman; Ronald P A Gaykema; Lisa E Goehler Journal: Am J Physiol Regul Integr Comp Physiol Date: 2010-11-10 Impact factor: 3.619
Authors: Laura L Raynor; Jeffrey J Saucerman; Modupeola O Akinola; Douglas E Lake; J Randall Moorman; Karen D Fairchild Journal: Pediatr Res Date: 2012-01-25 Impact factor: 3.756
Authors: Sarah A Coggins; Jörn-Hendrik Weitkamp; Lisa Grunwald; Ann R Stark; Jeff Reese; William Walsh; James L Wynn Journal: Arch Dis Child Fetal Neonatal Ed Date: 2015-10-30 Impact factor: 5.747
Authors: Samuel M Brown; M Quinn Tate; Jason P Jones; Kathryn G Kuttler; Michael J Lanspa; Matthew T Rondina; Colin K Grissom; V J Mathews Journal: J Intensive Care Med Date: 2014-02-26 Impact factor: 3.510
Authors: Travis J Moss; Douglas E Lake; J Forrest Calland; Kyle B Enfield; John B Delos; Karen D Fairchild; J Randall Moorman Journal: Crit Care Med Date: 2016-09 Impact factor: 7.598